Skip to main content

Remdesivir tied to lower COVID death rates in hospital patients receiving oxygen

By CIDRAP / University of Minnesota  
   September 25, 2023

A comparative-effectiveness study that spanned the dominance of SARS-CoV-2 variants of concern finds that the antiviral drug remdesivir significantly reduced in-hospital COVID-19 death rates among adults receiving supplemental oxygen on admission.

Full story

Get the latest on healthcare leadership in your inbox.